Dejerine–Roussy syndrome
Dejerine–Roussy syndrome (also known as thalamic pain syndrome, or central post-stroke pain) is a condition developed after a stroke at the level of the thalamus. The syndrome is named after two French neurologists, Joseph Jules Dejerine and Gustave Roussy, who first described the condition in 1906.
Symptoms[edit | edit source]
The main symptom of Dejerine–Roussy syndrome is chronic pain, which can be severe and is often resistant to treatment. The pain is typically on one side of the body and can be described as burning, aching, or pricking. Other symptoms can include sensory loss, hemiparesis (weakness on one side of the body), and hemianesthesia (loss of sensation on one side of the body).
Causes[edit | edit source]
Dejerine–Roussy syndrome is caused by a lesion in the thalamus, the part of the brain that relays sensory and motor signals to the cerebral cortex. This can occur as a result of a stroke, brain injury, or brain tumor.
Diagnosis[edit | edit source]
Diagnosis of Dejerine–Roussy syndrome is based on the patient's symptoms and medical history. Imaging tests such as MRI or CT scan may be used to confirm the presence of a thalamic lesion.
Treatment[edit | edit source]
Treatment for Dejerine–Roussy syndrome is focused on managing the chronic pain. This can include medications such as antidepressants, anticonvulsants, and opioids. In some cases, non-drug treatments such as physical therapy, occupational therapy, and cognitive behavioral therapy may be beneficial.
Prognosis[edit | edit source]
The prognosis for Dejerine–Roussy syndrome varies. Some patients may experience a reduction in pain over time, while others may continue to experience chronic pain despite treatment.
See also[edit | edit source]
References[edit | edit source]
Dejerine–Roussy syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD